EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)

Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment

Shabnam Radbakhsh, Diana Marisol Abrego-Guandique, Tiziana Bacchetti, Seyed Hamid Aghaee-Bakhtiari, Ali Mahmoudi, Ali Akhonpour Manteghi, Mohammad Javad Bazyari, Erika Cione, Gianna Ferretti, Amirhossein Sahebkar

Brain Research · 2025

DOI: 10.1016/j.brainres.2025.149607 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Brain Research, 2025. Verfasst von Shabnam Radbakhsh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Trehalose, Alzheimer Disease, Circulating MicroRNA, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Renal Society of Australasia, Università Politecnica delle Marche, Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trehalose has been proposed as a possible therapeutic option for attenuating the neuropathological changes associated with neurodegeneration, including Alzheimer's disease (AD). The administration of trehalose in human and murine models was linked to restoring antioxidant status, decreasing lipoperoxidation, and alleviating neuroinflammation. This latter biochemical mechanism was associated with the upregulation of specific brain-enriched microRNAs (miRNA). Herein, using a direct hybridization approach, we evaluate trehalose intravenous treatment in AD patients, conducting a phase two clinical trial (IRCT20130829014521N15) examining the alteration of microRNA profiles before and after the treatment. Twenty patients were recruited and randomly assigned to two groups: the intervention group received 15 g/week of intravenous trehalose. The control group received placebo in the form of normal saline. The period chosen was 12 weeks. Blood samples were obtained at the beginning and end of the study. Circulating microRNAs expression data between the placebo and treatment groups were assessed using microarray analysis. Subsequently, differentially expressed (DE) miRNAs specific to the trehalose-treated group were identified, and their gene targets were determined by bioinformatics-based approaches. The analysis of DE miRNAs pointed out modulation in unique miRNAs between treatment and placebo groups. Specifically, hsa-miR-1268a, -3605-3p, -555, and -6511a-3p were significantly downregulated, while hsa-miR-324-3p and -539-5p showed significant upregulation. Of the 147 overlapped validated genes identified in the bioinformatics analysis, several are related to autophagy, protein aggregation, oxidative stress, and inflammation. KEGG enrichment pathways reveal regulation of actin cytoskeleton, axon guidance, and neurotrophin signaling pathways. The results identify significant modulation in unique miRNAs in AD patients under trehalose. These findings suggest the potential utility of these microRNAs as biomarkers for trehalose pharmacological monitoring in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrehaloseAlzheimer DiseaseCirculating MicroRNAMicroRNAsHumansMaleFemaleComputational BiologyAgedMiddle AgedAdministration, Intravenous

Stichwörter der Autor:innen

Alzheimer’s diseaseBiomarkerDirect HybridizationMicroRNATrehalose

Substanzen

TrehaloseCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Health Sciences, University of Magna Graecia Catanzaro 88100 Catanzaro, Italy.
  • Department of Life and Environmental Sciences, Marche Polytechnic University, Via Brecce Bianche, 60131 Ancona, Italy.
  • Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pharmacy, Health, and Nutritional Sciences. Via Savinio, University of Calabria 87036 Rende, (CS), Italy.

Förderung

  • Renal Society of Australasia
  • Università Politecnica delle Marche
  • Mashhad University of Medical Sciences

Zitieren

APA

Radbakhsh, S., Abrego-Guandique, D. M., Bacchetti, T., Aghaee-Bakhtiari, S. H., Mahmoudi, A., Manteghi, A. A., Bazyari, M. J., Cione, E., Ferretti, G., & Sahebkar, A. (2025). Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment. Brain Research. https://doi.org/10.1016/j.brainres.2025.149607

Vancouver

Radbakhsh S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, Mahmoudi A, Manteghi AA, et al. Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment. Brain Research. 2025. doi:10.1016/j.brainres.2025.149607

BibTeX
@article{Radbakhsh2025,
  author = {Radbakhsh, Shabnam and Abrego-Guandique, Diana Marisol and Bacchetti, Tiziana and Aghaee-Bakhtiari, Seyed Hamid and Mahmoudi, Ali and Manteghi, Ali Akhonpour and Bazyari, Mohammad Javad and Cione, Erika and Ferretti, Gianna and Sahebkar, Amirhossein},
  title = {Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer’s disease under intravenous trehalose treatment},
  journal = {Brain Research},
  year = {2025},
  doi = {10.1016/j.brainres.2025.149607}
}
Kostenlos starten →